...
首页> 外文期刊>Human Reproduction >Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged >= 35 years: a randomized controlled trial
【24h】

Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged >= 35 years: a randomized controlled trial

机译:≥35岁患者在GnRH拮抗剂卵巢刺激过程中重组卵泡刺激素和重组黄体生成素与重组卵泡刺激素的比较:一项随机对照试验

获取原文
获取原文并翻译 | 示例
           

摘要

STUDY QUESTION: Does luteinizing hormone (LH) supplementation improve live birth rate after in vitro fertilization (IVF) in patients aged >= 35 years receiving a gonadotrophin-releasing hormone (GnRH) antagonist protocol?
机译:研究问题:≥35岁接受促性腺激素释放激素(GnRH)拮抗剂治疗的患者,补充黄体激素(LH)是否可以提高体外受精(IVF)后的活产率?

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号